Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU)

1. S. C. Sweetman, Martindale the Complete Drug Reference (Ed. S. C. Sweetman), 34th ed., Pharmaceutical Press, London 2005, pp. 554-556.Search in Google Scholar

2. E. Reed, J. Jacob, R. F. Ozols, R. C. Young and C. Allegra, 5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma, Gynecol. Oncol. 46 (1992) 326-329; DOI: 10.1016/0090-8258(92)90226-9.10.1016/0090-8258(92)90226-9Search in Google Scholar

3. www.rxlist.com, accessed on 25th July 2011.Search in Google Scholar

4. A. Goodman and L. Gilman, Antineoplastic Agents, in Manual of Pharmacology and Therapeutics (Ed. K. Parker), 11th ed., McGraw Hill, New York 2008, pp. 874-876.Search in Google Scholar

5. M. Markman, Intraperitoneal antineoplastic drug delivery: rationale and results, Lancet Oncol. 4 (2003) 277-283; DOI: 10.1016/S1470-2045(03)01074-X.10.1016/S1470-2045(03)01074-XSearch in Google Scholar

6. A. Chenite, M. Buschmann, D. Wang, C. Chaput and N. Kandani, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym. 46 (2001) 39-47; DOI: 10.1016/S0144-8617(00)00281-2.10.1016/S0144-8617(00)00281-2Search in Google Scholar

7. W. Jie, S. Zhi-Guo and M. Guang-Hui, A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate, Int. J. Pharm. 315 (2006) 1-11; DOI: 10.1016/j.ijpharm.2006.01.04.Search in Google Scholar

8. Y. Wang, N. Xu, Q. Luo, Y. Li, L. Sun, H. Wang, K. Xu, B. Wang and Y. Zhen, In vivo assessment of chitosan/â-glycerophosphate as a new liquid embolic agent, Interv. Neuroradiol. 17 (2011) 87-92.10.1177/159101991101700114Search in Google Scholar

9. E. Ruel-Gariepy and L. Jean-Christophe, In situ-forming hydrogels-review of temperature-sensitive systems, Eur. J. Pharm. Biopharm. 58 (2004) 409-426; DOI: 10.1016/j.ejpb.2004.03.019.10.1016/j.ejpb.2004.03.019Search in Google Scholar

10. E. Ruel-Gariepy, A. Chenite, C. Chaput, S. Guirguis and J. Leroux, Characterization of thermosensitive chitosan gels for the sustained delivery of drugs, Int. J. Pharm. 203 (2000) 89-98; DOI: 10.1016/S0378-5173(00)00428-2.10.1016/S0378-5173(00)00428-2Search in Google Scholar

11. OECD guideline 425 for the testing of chemicals. Section 4, Acute Oral Toxicity: Up-and-Down Procedure.Search in Google Scholar

12. G. Carlsson, B. Gullberg and L. Hafstrom, Estimation of liver tumor volume using different formulas - an experimental study in rats, J. Cancer Res. Clin. Oncol. 105 (1983) 20-23; DOI: 10.1007/ BF00391826.10.1007/BF00391826Search in Google Scholar

13. M. M. Tomayko and C. P. Reynolds, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol. 24 (1989) 148-154; DOI: 10.1007/BF00300234.10.1007/BF00300234Search in Google Scholar

14. B. Jeong, S. W. Kim and Y. H. Bae, Thermosensitive sol-gel reversible hydrogels, Adv. Drug Deliv. Rev. 54 (2002) 37-51; DOI: 10.1016/S0169-409X(01)00242-3.10.1016/S0169-409X(01)00242-3Search in Google Scholar

15. F. Ganji, M Abdekhodaie and S. A. Ramazani, Gelation time and degradation rate of chitosan- -based injectable hydrogel, J. Sol-Gel Sci. Tech. 42 (2007) 47-53; DOI: 10.1007/s10971-006-9007-1.10.1007/s10971-006-9007-1Search in Google Scholar

16. D. Anderson and D. M. Conning, Experimental Toxicology: the Basic Issues, 2nd ed., Royal Society of Chemistry, California 1993, p. 17.Search in Google Scholar

17. A. M. Fan, L. W. Chang, Toxicology and Risk Assessment; Principles, Methods and Application, 4th ed., Marcel Dekker Inc., New York 1996, pp. 108-110.Search in Google Scholar

18. J. L. Speyer, P. H. Sugarbaker, J. M. Collins, R. L. Dedrick, R. W. Klecker and C. E. Myers, Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans, Cancer Res. 41 (1981) 1916-1922.Search in Google Scholar

19. M. J. Ellenhorn, Ellenhorn’s Medicinal Toxicology; Diagnosis and Treatment of Human Poisoning (Ed. M. J. Ellenhorn), 2nd ed., Williams and Wilkins, Baltimore 1997, p. 1326.Search in Google Scholar

20. R. L. Schilsky, K. E. Choi, J. Grayhack, D. Grimmer, C. Guarnieri and L. Fullem, Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intra-abdominal cancer, J. Clin Oncol. 8 (1990) 2054-2061.10.1200/JCO.1990.8.12.2054Search in Google Scholar

21. M. Ravi Kumar, R. Muzzarelli and C. Muzzarelli, Chitosan chemistry and pharmaceutical perspectives, Chem. Rev. 104 (2004) 6017-6084; DOI: 10.1002/chin.200511296.10.1002/chin.200511296Search in Google Scholar

22. R. Zange, Y. Li and T. Kissel, Biocompatibility testing of ABA triblock copolymers consisting of poly (L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models, J. Control. Release 56 (1998) 249-258; DOI: 10.1016/S0168-3659(98)00093-5.10.1016/S0168-3659(98)00093-5Search in Google Scholar

23. R. Ahmadi, M. Zhou, J. D. De Bruijn, The use of thermo-sensitive chitosan as an injectable carrier for bone tissue engineering, Eur. Cell Mater. 10 (2005) 61. Search in Google Scholar